| |||||||||||||||
BIBE 2023 : The Seventh International Conference on Biological Information and Biomedical Engineering | |||||||||||||||
Link: http://www.icbibe.org/ | |||||||||||||||
| |||||||||||||||
Call For Papers | |||||||||||||||
BIBE2023 The Seventh International Conference on Biological Information and Biomedical Engineering
Website:http://www.icbibe.org/ Conference date:July 18-20, 2023 Conference location:Kunming, China The Seventh International Conference on Biological Information and Biomedical Engineering (BIBE2023) will be held in Kunming, China from July 18 to 20, 2023. The purpose of the BIBE2023 is to promote the exchange of experts in the field of biological information and biomedical engineering, and to provide an international cooperation and exchange platform for experts, scholars and enterprise developers to share research results, discuss existing problems and challenges, and explore the latest development trends. BIBE is a leading annual conference of biological information and biomedical engineering for all researchers at home and abroad since 2016. So far, it has attracted about 400 experts, scholars and students from China, the United States, Japan, Russia and other countries and regions to attend the conference, providing a high-quality exchange platform for innovative scholars and industry experts in the field. All previous BIBE conference papers have been strictly peer-reviewed, and the high-quality papers selected by BIBE2016 have been included in SCI. BIBE2018-2020 all accepted papers have been published successfully, and were indexed by Ei Compendex, Scopus, etc. BIBE2021 all accepted papers have been published online by ACM Digital Library, and were indexed by Ei Compendex, Scopus, etc. All papers accepted by BIBE2023 will be published by VDE VERLAG GmbH, which will be included in IEEE Xplore Digital Library, provided to the Ei Compendex, Scopus, etc. to ensure maximum awareness of the Proceedings On behalf of BIBE2023 Organizing Committee, we sincerely invite experts, scholars and researchers to participate in the conference and contribute. BIBE history Conference publication Index BIBE2021 ACM (ISBN: 978-1-4503-8929-7) EI and Scopus BIBE2020 ACM (ISBN: 978-1-4503-7709-6) EI and Scopus BIBE2019 VDE (ISBN: 978-3-8007-5026-9) EI and Scopus BIBE2018 VDE (ISBN: 978-3-8007-4727-6) EI and Scopus Topics The topics of the paper submitted to BIBE2023 are included but not limited to: Biological Information: Genomics Proteomics DNA sequence analysis Protein encoding Protein space structure simulation Genetic information Genetic engineering Protein alignment Gene expression Molecular biology Gene recognition analysis Gene drugs Molecular evolution Biomedical Engineering: Medical sensor Digital signal processing Medical image processing Biomedical materials Medical nanotechnology Medical imaging instrument Medicine Diagnostics Surgery Physiology Cell therapy technology Principle of medical instrument Medical electronics Biological pharmacy Individualized treatment Submission Guidelines 1. Manuscripts Preparation Please refer to the conference website to download the format instruction for manuscripts. 2. Submitting an Article Enter the online submission system, register and upload the file in the submission system. Or send your paper to the official email Secretary@icbibe.org with your telephone number. 3. About Academic Misconduct All submitted articles should report original, previously unpublished research results, experimental or theoretical. Articles submitted to the conference should meet these criteria and must not be under consideration for publication elsewhere. We firmly believe that ethical conduct is the most essential virtual of any academic. Hence any act of plagiarism is a totally unacceptable academic misconduct and cannot be tolerated. Participants Guidelines Please send the application to the mailbox: Secretary@icbibe.org About the registration fee, please refer to http://www.icbibe.org/ for more information. Contact us Email: Secretary@icbibe.org Tel:+86-18771047473 QQ: 1960740002 |
|